1 Introduction
2 Methods
2.1 General descriptions
-
The relationship between ground surface emission and an increase in tropospheric chlorine loading (TCL) for the 13 ODSs.
-
The relationship between an increase in TCL and an increase in EESC for the 13 ODSs.
-
The relationship between ground surface emission and an increase in EESC for N2O was calculated in this study using the ODPs and atmospheric lifetimes of N2O and CFC-11 (Sect. 2.2).
-
The relationship between the total EESC and total O3 was revised in this study (Sect. 2.3).
-
The relationship between total O3 and UV-B at the ground surface.
-
The correction of the ground-level UV-B into erythemal UV-B.
-
The correction of the atmospheric lifetimes of ODSs, updated in this study (Sect. 2.4).
-
The incidence rates of skin cancer and eye cataracts tied to erythemal UV-B exposure, which denote the rate to unit emission per 100,000 individuals. The skin cancer types were divided into malignant melanoma and non-melanoma skin cancer for fair, medium, and dark skin colors.
-
The global latitudinal population was updated in this study for 2010 and 2015. The population distinguishing the three skin colors (fair, medium, and dark) was estimated for each 10° latitudinal belt (Sect. 2.5).
-
An increase in the total incidence of each disease per unit emission of ODSs was calculated using the abovementioned relationships.
-
DALYs per incidence of melanoma, non-melanoma skin cancer, and eye cataracts were updated in this study for 2010 and 2015 (Sect. 2.6).
2.2 Relationship between surface N2O emission and EESC
2.3 Update of relationship between EESC and total O3
2.4 Update of atmospheric lifetime of ODSs
ODS species | Lifetime in literature (year) | Reference: lifetime used in the previous studyc (year) | ||
---|---|---|---|---|
CFSs | CFC-11 | 52a | 49.1 | 45d |
CFC-12 | 102a | 99.0 | 100d | |
CFC-113 | 93a | 90.0 | 85d | |
Halons | Halon-1211 | 16a | 13.3 | 11d |
Halon-1301 | 72a | 69.1 | 65d | |
Carbon tetrachloride (CCl4) | 32a | 29.1 | 35d | |
Methyl chloroform (CH3CCl3) | 5.0a | 2.74 | 4.8d | |
HCFCs | HCFC-22 | 11.9a | 9.2 | 11.8d |
HCFC-123 | 1.3a | 0.129 | 1.4d | |
HCFC-124 | 5.9a | 3.55 | 6.1d | |
HCFC-141b | 9.4a | 6.83 | 9.2d | |
HCFC-142b | 18.0a | 15.2 | 18.5d | |
Methyl bromide (CH3Br) | 0.8a | 0.019 | 0.7d | |
Nitrous oxide (N2O) | 109b | 106 | Not subject |
2.5 Update of global latitudinal population
2.6 Update of DALYs for skin cancer and eye cataract
Disease | DALY per incidence (DALY case–1) | ||
---|---|---|---|
2010 | 2015 | Ca. 2000a | |
Malignant melanoma | 6.31 | 6.02 | 5.9 |
Non-melanoma skin cancer | 0.196 | 0.193 | 0.34 |
Eye cataract | 1.05 | 1.07 | 1.2 |
3 Results and discussion
3.1 Estimated damage for major ODSs
ODS species | Increase in total cases per unit emission (case Gg–1 for 13 ODSs, case Gg–1 N for N2O) | ||||||
---|---|---|---|---|---|---|---|
2010 | 2015 | ||||||
Melanoma | Non-melanoma | Eye cataract | Melanoma | Non-melanoma | Eye cataract | ||
CFSs | CFC-11 | 15.0 | 876 | 577 | 15.5 | 897 | 612 |
CFC-12 | 13.8 | 803 | 529 | 14.2 | 823 | 561 | |
CFC-113 | 15.2 | 883 | 582 | 15.6 | 905 | 617 | |
Halons | Halon-1211 | 51.0 | 2972 | 1950 | 52.4 | 3040 | 2070 |
Halon-1301 | 209 | 12200 | 8010 | 215 | 12500 | 8500 | |
Carbon tetrachloride (CCl4) | 11.3 | 656 | 432 | 11.6 | 672 | 459 | |
Methyl chloroform (CH3CCl3) | 0.94 | 54.5 | 35.9 | 0.96 | 55.8 | 38.1 | |
HCFCs | HCFC-22 | 0.53 | 30.6 | 20.1 | 0.54 | 31.3 | 21.4 |
HCFC-123 | 0.03 | 1.53 | 1.01 | 0.03 | 1.57 | 1.07 | |
HCFC-124 | 0.19 | 11.0 | 7.27 | 0.19 | 11.3 | 7.72 | |
HCFC-141b | 1.18 | 68.7 | 45.3 | 1.21 | 70.4 | 48.0 | |
HCFC-142b | 0.77 | 44.6 | 29.4 | 0.79 | 45.7 | 31.2 | |
Methyl bromide (CH3Br) | 0.12 | 7.06 | 4.64 | 0.12 | 7.23 | 4.92 | |
Nitrous oxide (N2O) (ODP: 0.015) | 0.36 | 20.7 | 13.7 | 0.37 | 21.2 | 14.5 |
ODS species | Damage function (DALYs) per unit emission (DALY kg–1 for 13 ODSs, DALY kg–1 N for N2O) | ||||||||
---|---|---|---|---|---|---|---|---|---|
2010 | 2015 | ||||||||
Melanoma | Non-melanoma | Eye cataract | Total | Melanoma | Non-melanoma | Eye cataract | Total | ||
CFSs | CFC-11 | 9.49E–5 | 1.72E–4 | 6.07E–4 | 8.74E–4 | 9.31E–5 | 1.73E–4 | 6.56E–4 | 9.22E–4 |
CFC-12 | 8.70E–5 | 1.58E–4 | 5.56E–4 | 8.01E–4 | 8.53E–5 | 1.58E–4 | 6.02E–4 | 8.46E–4 | |
CFC-113 | 9.57E–5 | 1.74E–4 | 6.12E–4 | 8.81E–4 | 9.38E–5 | 1.74E–4 | 6.62E–4 | 9.30E–4 | |
Halons | Halon-1211 | 3.22E–4 | 5.84E–4 | 2.06E–3 | 2.96E–3 | 3.16E–4 | 5.86E–4 | 2.22E–3 | 3.13E–3 |
Halon-1301 | 1.32E–3 | 2.39E–3 | 8.43E–3 | 1.21E–2 | 1.29E–3 | 2.40E–3 | 9.12E–3 | 1.28E–2 | |
Carbon tetrachloride (CCl4) | 7.11E–5 | 1.29E–4 | 4.55E–4 | 6.55E–4 | 6.97E–5 | 1.29E–4 | 4.92E–4 | 6.91E–4 | |
Methyl chloroform (CH3CCl3) | 5.90E–6 | 1.07E–5 | 3.77E–5 | 5.43E–5 | 5.79E–6 | 1.07E–5 | 4.08E–5 | 5.73E–5 | |
HCFCs | HCFC-22 | 3.31E–6 | 6.01E–6 | 2.12E–5 | 3.05E–5 | 3.25E–6 | 6.03E–6 | 2.29E–5 | 3.22E–5 |
HCFC-123 | 1.66E–7 | 3.01E–7 | 1.06E–6 | 1.53E–6 | 1.63E–7 | 3.03E–7 | 1.15E–6 | 1.62E–6 | |
HCFC-124 | 1.20E–6 | 2.17E–6 | 7.65E–6 | 1.10E–5 | 1.17E–6 | 2.18E–6 | 8.28E–6 | 1.16E–5 | |
HCFC-141b | 7.44E–6 | 1.35E–5 | 4.76E–5 | 6.86E–5 | 7.30E–6 | 1.36E–5 | 5.15E–5 | 7.24E–5 | |
HCFC-142b | 4.83E–6 | 8.76E–6 | 3.09E–5 | 4.45E–5 | 4.74E–6 | 8.79E–6 | 3.34E–5 | 4.69E–5 | |
Methyl bromide (CH3Br) | 7.28E–7 | 1.39E–6 | 4.88E–6 | 7.00E–6 | 7.12E–7 | 1.39E–5 | 5.28E–6 | 7.38E–6 | |
Nitrous oxide (N2O) (ODP: 0.015) | 2.25E–6 | 4.07E–6 | 1.44E–5 | 2.07E–5 | 2.20E–6 | 4.09E–6 | 1.55E–5 | 2.18E–5 |
3.2 Sources of uncertainty
3.3 Sensitivity analysis
Parameter | Response of damage factor to a 10% increase in parameter |
---|---|
Slope of EESC–total O3 (latitudinal belt, season) Atmospheric lifetime (CFC-11) ODP (N2O) UV-B irradiance (top of the atmosphere) Total population | 11.4% 10.6% 10.0% 10.0% 10.0% |
Population ratio (latitudinal belt, fair skin) dEESC(CFC-11) Erythemal correction factor (300–310 nm) DALY (non-melanoma) Incidence rate factor (non-melanoma, fair skin) | 9.7% 9.5% 6.9% 6.4% 6.4% |
DALY (melanoma) Incidence rate factor (melanoma, fair skin) Erythemal correction factor (310–320 nm) Total EESC in base year Incidence rate factor (melanoma, medium skin) Incidence rate factor (melanoma, dark skin) Incidence rate factor (non-melanoma, medium skin) | 3.6% 3.4% 1.7% 1.3% 0.1% 0.1% 0.1% |
Incidence rate factor (non-melanoma, dark skin) | 0.0% |
Atmospheric lifetime (N2O) | 0.0% |